Sign in

CIK 0001817241 · <br>Emerging growth company

Artiva Biotherapeutics, Inc.

Sign in to watch
Ticker
ARTV
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863614316
Phone
(858) 267-4467
Business address
5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
  1. 8-K/A Event Exit or restructuring costs
  2. 10-Q Report Quarterly Report
  3. 4 Open-market sale Chief Tech Operations Officer sold 10,423 shares at $4.18 ($43,580)
  4. 4 Open-market sale COO, CLO, Compliance Officer sold 8,439 shares at $4.18 ($35,284)
  5. 4 Open-market sale Chief Medical Officer sold 1,110 shares at $4.18 ($4,641)
  6. 4 Open-market sale Chief Executive Officer sold 62,178 shares at $4.18 ($259,972)
  7. 8-K Event Results of operations · Exit or restructuring costs
  8. 4 Planned sale Chief Executive Officer sold 23,463 shares at $7.20 ($168,880)
  9. 144 Insider Sale of Securities
  10. 4 Open-market sale Chief Tech Operations Officer sold 10,340 shares at $6.84 ($70,697)
  11. 4 Open-market sale COO, CLO, Compliance Officer sold 8,370 shares at $6.84 ($57,227)
  12. 4 Open-market sale Chief Medical Officer sold 1,099 shares at $6.84 ($7,514)
  13. 4 Open-market sale Chief Executive Officer sold 61,696 shares at $6.84 ($421,828)
  14. 4 Grant or award Chief Executive Officer acquired 110,000 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 45,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 12 · 234 filings